Peers & Perspectives

The Variations of ADHD

ADHD Signs and Symptoms

How ADHD Affects Quality of Life

AAP and SDBP Updated Diagnostic and Treatment Guidelines

Diagnostic Complications: Comorbid Psychiatric Disorders

ADHD Management: Nonpharmacological Approach

ADHD Pharmacological Approach: Stimulants

Novel Therapy Approach to Managing ADHD

SPN-812 Tolerability Profile

ADHD Difficulties During Coronavirus Pandemic

Clinician Advice for Managing ADHD During COVID-19

Consequences of Hypercholesterolemia

Cardiovascular Disease Risk Factors

Socioeconomic Status and Hypercholesterolemia

Cardiovascular Disease in Younger Populations

Lifestyle Modifications to Manage Hypercholesterolemia

Hypercholesterolemia: Shared Decision-Making

Selecting a Statin Therapy to Manage LDL-C

Managing Intolerance to Statin Therapy

PCSK9 Inhibitors and LDL-C Reduction

Cardiovascular Outcomes: FOURIER and ODYSSEY

Lipoprotein(a) and PCSK9 Utilization

Real-World Experience With PCSK9 Inhibitors

Increasing Confidence in Prescribing PCSK9 Inhibitors

ACS: Early Intervention With PCSK9 Therapy

Risk Factors Causing Complications Due to COVID-19

Lack of Herd Immunity to COVID-19

Effect of Viral Mutations on the Spread and Severity of COVID-19

Vaccine Development to Protect Against Coronavirus

Reluctance in Getting Vaccinated to Prevent Coronavirus

Cardiac Biomarker Assessment for Patients With COVID-19

Treating Cardiovascular Risks in Patients Tested for COVID-19

Effects of IPE on Inflammatory Biomarkers in Patients With COVID-19

Other Agents Used to Treat Cardiovascular Patients With COVID-19

Telehealth Strategies for Patients During COVID-19 Pandemic

Lifestyle Modifications for Patients to Adapt During COVID-19

Cardiac Injury and Mortality

Complication Risk in Patients With COVID-19 & Thrombosis

Anticoagulants and COVID-19 Complications

Inpatient Services: COVID-19 and DOACs Management

Underlying Respiratory Comorbidities and COVID-19

Stratifying Patients as High-Risk With COVID-19

DVT/VTE Prophylaxis Guidelines

Venous Thromboembolism Postdischarge Risk

The Future of COVID-19 and Thromboprophylaxis Treatment

Causes of Drug Shortages in the United States

Navigating Through Drug Shortages in the Pharmacy

Addressing the Heparin Drug Shortage

Defining Medically Ill Patients for VTE Prophylaxis

Comparison of DOACs Available for VTE Prophylaxis

Implications for Treating With a DOAC for VTE Prophylaxis

Selecting & Utilizing a DOAC for VTE Prophylaxis

Addressing Drug Shortages in the United States

The Current Applications of and Opportunities for AI in Healthcare

Balancing FDA Regulation With Technology Innovation

The Implementation Hurdles Associated With Adoption of AI and Robotics

The Acquisition of Data and the Issue of Privacy

Facial Recognition and the Future of AI in Medicine

Fighting Bias in Data and AI

Telemedicine and Technology Infrastructure

Future Opportunities for AI Integration

The Definition of AI and Innovation Opportunities in Medicine